BioSpace News Archive

Tablet-Based Device Manager Provides Portable and Secure Wireless Programming of Medtronic BlueSync(TM) Devices

Hansa Biopharma AB announced that IDEFIRIX, the Company’s novel IgG-degrading enzyme, will be highlighted in three presentations at the upcoming 2019 American Transplant Congress, which will be held from June 1 – 5, 2019 in Boston, Massachusetts, USA.

GenomOncology announces Northwestern Memorial Healthcare has chosen the GenomOncology Pathology Workbench system as part of its clinical analysis process for their latest Oncomine Comprehensive NGS Assay.

Concept Medical Inc. has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration for MagicTouch, its Sirolimus drug-coated balloon catheter, for the treatment of coronary in-stent restenosis.

Net sales of $19.6 billion were down 9 percent compared with the year-ago period on lower local price of 4 percent, a 3 percent currency headwind and volume declines of 2 percent.

Milestones anticipated throughout 2019 in clinical studies across all three franchises: depression, neurology and neuropsychiatry

Revenues of $43.3 billion for the Second Quarter, a 5.6 Percent Increase Year-Over-Year

19 abstracts to be presented, including Phase 3, eight-week data on Emgality for the preventive treatment of episodic cluster headache in adults, featured in a plenary presentation

The West Palm Beach Practice Marks First Add-On For Water’s Edge Under Gryphon Ownership

Intec Pharma Ltd. announces that the results from a pharmacokinetics study of the Accordion Pill™-Carbidopa/Levodopa 50/500 mg dosed three times per day was accepted for presentation in a poster at the upcoming XXIV World Congress on Parkinson’s Disease and Related Disorders taking place June 16-19, 2019 at the Lyon Convention Centre in Montreal, Canada.